Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 505

1.

Carcinogen exposure during short-term switching from regular to "light" cigarettes.

Benowitz NL, Jacob P 3rd, Bernert JT, Wilson M, Wang L, Allen F, Dempsey D.

Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1376-83.

2.

Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette.

Benowitz NL, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P 3rd.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2479-85.

3.

Smoking topography, brand switching, and nicotine delivery: results from an in vivo study.

Hammond D, Fong GT, Cummings KM, Hyland A.

Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1370-5.

4.
5.

Smoking behaviour and compensation: a review of the literature.

Scherer G.

Psychopharmacology (Berl). 1999 Jul;145(1):1-20. Review.

PMID:
10445368
6.

Urinary tobacco-specific nitrosamines and 4-aminobiphenyl hemoglobin adducts measured in smokers of either regular or light cigarettes.

Bernert JT, Jain RB, Pirkle JL, Wang L, Miller BB, Sampson EJ.

Nicotine Tob Res. 2005 Oct;7(5):729-38.

PMID:
16191744
7.

Smokers of menthol and nonmenthol cigarettes exhibit similar levels of biomarkers of smoke exposure.

Heck JD.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):622-9. doi: 10.1158/1055-9965.EPI-08-0550. Epub 2009 Feb 3. Erratum in: Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2155.

8.

Effect of delivered dosage of cigarette smoke toxins on the levels of urinary biomarkers of exposure.

Melikian AA, Djordjevic MV, Chen S, Richie J Jr, Stellman SD.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1408-15.

9.

The tar reduction study: randomised trial of the effect of cigarette tar yield reduction on compensatory smoking.

Frost C, Fullerton FM, Stephen AM, Stone R, Nicolaides-Bouman A, Densem J, Wald NJ, Semmence A.

Thorax. 1995 Oct;50(10):1038-43.

10.

Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany.

Scherer G, Engl J, Urban M, Gilch G, Janket D, Riedel K.

Regul Toxicol Pharmacol. 2007 Mar;47(2):171-83. Epub 2006 Oct 10.

PMID:
17034917
11.

Doses of nicotine and lung carcinogens delivered to cigarette smokers.

Djordjevic MV, Stellman SD, Zang E.

J Natl Cancer Inst. 2000 Jan 19;92(2):106-11.

PMID:
10639511
12.

Cigarette brand-switching: effects on smoke exposure and smoking behavior.

Zacny JP, Stitzer ML.

J Pharmacol Exp Ther. 1988 Aug;246(2):619-27.

PMID:
3404450
13.
14.

Self-regulation of smoking intensity. Smoke yields of the low-nicotine, low-'tar' cigarettes.

Djordjevic MV, Fan J, Ferguson S, Hoffmann D.

Carcinogenesis. 1995 Sep;16(9):2015-21.

PMID:
7554048
15.

Nicotine intake and dose response when smoking reduced-nicotine content cigarettes.

Benowitz NL, Jacob P 3rd, Herrera B.

Clin Pharmacol Ther. 2006 Dec;80(6):703-14.

PMID:
17178270
16.

Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke.

Melikian AA, Djordjevic MV, Hosey J, Zhang J, Chen S, Zang E, Muscat J, Stellman SD.

Nicotine Tob Res. 2007 Mar;9(3):377-87.

PMID:
17365769
17.

Measurement of self reported active exposure to cigarette smoke.

Etter JF, Perneger TV.

J Epidemiol Community Health. 2001 Sep;55(9):674-80.

18.

Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes.

Hecht SS, Murphy SE, Carmella SG, Li S, Jensen J, Le C, Joseph AM, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):693-8. Erratum in: Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1568.

19.

Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.

Rose JE, Behm FM.

Nicotine Tob Res. 2004 Jun;6(3):523-32.

PMID:
15203786
20.

Supplemental Content

Support Center